Product Information

CITALOPRAM HBR 10 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0300 per EA under NDC 69097082212. Its NADAC has been published 522 times since Nov 23, 2016.

FDA first approved this application on Oct 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CITALOPRAM HBR 10 MG TABLET

Citalopram
$0.0300per EA

Strength

10 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097082212

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CITALOPRAM HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077534

FDA Approved

10/3/2006

TE Code

AB

On Market Since

7/22/2016

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for CITALOPRAM HBR 10 MG TABLET has been published 522 times since Nov 23, 2016, and over the history we have for it it has declined 6.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0300 per EA
All-time high$0.0359 (Jan 11, 2017)
All-time low$0.0204 (May 22, 2024)
52-week high$0.0300
52-week low$0.0241
Median price$0.0271
Average price$0.0274
Largest weekly change+24.2% (Jun 19, 2024)
Weeks tracked522
Tracking sinceNov 23, 2016

Price History

1W

+5.0%

1M

+15.2%

3M

+21.8%

6M

+17.4%

1Y

+25.0%

3Y

+14.5%

5Y

+14.1%

All

-6.8%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CITALOPRAM HBR 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 10 MG TABLET, manufactured by Cipla USA Inc., is $0.0300 per EA (NDC 69097082212), effective Nov 18, 2026.

How has the price of CITALOPRAM HBR 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for CITALOPRAM HBR 10 MG TABLET has declined 6.8%. It has been tracked across 522 weekly CMS publications since Nov 23, 2016.

What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 10 MG TABLET?

Since Nov 23, 2016, the NADAC for CITALOPRAM HBR 10 MG TABLET has ranged from a low of $0.0204 (May 22, 2024) to a high of $0.0359 (Jan 11, 2017), with a median of $0.0271 per EA.

Are there cheaper alternatives to CITALOPRAM HBR 10 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CITALOPRAM HBR 10 MG TABLET, is $0.0261 per EA — about 13% below CITALOPRAM HBR 10 MG TABLET.

Who manufactures CITALOPRAM HBR 10 MG TABLET?

CITALOPRAM HBR 10 MG TABLET (NDC 69097082212) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.